A. Tuba Kendi

机构：Mayo Clinic, WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida · ORCID：0000-0003-3892-4754

发表论文 134 篇 · 总被引 2745 次 · h-index 26

代表论文

Quantitative 68 Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177 Lu-PSMA-617 (VISION Trial) (2024 · Radiology · 被引 105)
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors (2024 · CA A Cancer Journal for Clinicians · 被引 47)
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going (2024 · Cancer Treatment Reviews · 被引 28)
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy (2024 · Frontiers in Oncology · 被引 18)
Current and future directions in theranostics for neuroendocrine prostate cancer (2025 · Cancer Treatment Reviews · 被引 13)
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy (2024 · Journal of Nuclear Medicine · 被引 13)